Clorazepate dipotassium (Tranxene): a controlled evaluation in alcoholic patients after withdrawal.
D000328:Adult; D000437:Alcoholism / Q000188:drug therapy*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003009:Clorazepate Dipotassium / Q000009:adverse effects / Q000627:therapeutic use*; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D010919:Placebos; D003009:Clorazepate Dipotassium; D003975:Diazepam